UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013207
Receipt number R000015410
Scientific Title Reversibility of Rocuronium-induced Profound Neuromuscular Blockade with Sugammadex in pediatric patient.
Date of disclosure of the study information 2014/02/20
Last modified on 2014/02/20 16:48:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Reversibility of Rocuronium-induced Profound Neuromuscular Blockade with Sugammadex in pediatric patient.

Acronym

Reversibility of Rocuronium-induced Profound Neuromuscular Blockade with Sugammadex in pediatric patient.

Scientific Title

Reversibility of Rocuronium-induced Profound Neuromuscular Blockade with Sugammadex in pediatric patient.

Scientific Title:Acronym

Reversibility of Rocuronium-induced Profound Neuromuscular Blockade with Sugammadex in pediatric patient.

Region

Japan


Condition

Condition

Surgical pediatric patients requiring general anesthesia.

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to clarify an adequate dose and to research characteristics of sugammadex to reverse profound rocuronium-induced neuromuscular blockade in pediatric patients by acceleromyography.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The duration of the recovery to a TOF ratio of 0.9 and 90% of control in T1 after sugammadex was administered.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

At reappearance of 1-2 PTC, a single bolus dose of 1.0mg/kg sugammadex was randomly administered. If there were residual neuromuscular blockade and recurarization, supplementary sugammadex were administered at recovery to a TOF ratio of 0.9.

Interventions/Control_2

At reappearance of 1-2 PTC, a single bolus dose of 2.0mg/kg sugammadex was randomly administered. If there were residual neuromuscular blockade and recurarization, supplementary sugammadex were administered at recovery to a TOF ratio of 0.9.

Interventions/Control_3

At reappearance of 1-2 PTC, a single bolus dose of 4.0mg/kg sugammadex was randomly administered. If there were residual neuromuscular blockade and recurarization, supplementary sugammadex were administered at recovery to a TOF ratio of 0.9.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <=

Age-upper limit

24 months-old >

Gender

Male and Female

Key inclusion criteria

1)Patients aged 1-23 month
2) Patients of ASA risk classification 1-3
3) Patients that a written informed consent was obtained to participate in this study.

Key exclusion criteria

1)Patients had or suspected neuromuscular disorders.
2)Patients had a hstory of allergy to any medication used during anesthesia.
3) Patients had a history of malignant hyperthermia.
4)Patients had significant hepatic and renal disfunction.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinichi Yamamoto

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Department of Anesthesiology

Zip code


Address

2-8-29 Musashidai Fuchu-shi Tokyo

TEL

042-300-5111

Email

shinichi_yamamoto@tmhp.jp


Public contact

Name of contact person

1st name
Middle name
Last name Chihiro Sekijima

Organization

Saitama Children's Medical Center

Division name

Department of Anesthesiology

Zip code


Address

2100 Magome, Iwatsuki-ku, Saitama 339-8551, Japan

TEL

048-758-1811

Homepage URL


Email

c52yamaguchi@yahoo.co.jp


Sponsor or person

Institute

Tokyo Metropolitan Children's Medical Center

Institute

Department

Personal name



Funding Source

Organization

Tokyo Metropolitan Children's Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 02 Month 20 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 11 Month 12 Day

Last follow-up date

2011 Year 10 Month 03 Day

Date of closure to data entry

2011 Year 10 Month 03 Day

Date trial data considered complete

2011 Year 10 Month 03 Day

Date analysis concluded

2011 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2014 Year 02 Month 20 Day

Last modified on

2014 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015410


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name